Home›People›Samraat Raha
SR

Samraat Raha

Chief executive officer of Myriad Genetics.

Director
Updated Nov 6, 2026·Latest SEC filing Nov 3, 2026·Suggest an edit

About Samraat Raha

Samraat Raha is chief executive officer of Myriad Genetics. Before that, he was president of Agilent's Diagnostics and Genomics Group, where he was responsible for the group's strategy, business and financial results. Earlier, he was vice president of global marketing at Illumina.

Raha is an independent board member of Araceli Biosciences, which makes high-content imaging and AI analysis systems for drug discovery labs.

Experience

This experience comes from official bios and from SEC filings. For roles taken from filings, the years are when the filings name Samraat Raha in the role, so the role may have started earlier or lasted longer.

Araceli Biosciences Inc. Current
Independent Board Member
2023 – Present · Tigard, OR
Araceli Biosciences makes high-content imaging and AI analysis systems that help drug discovery labs screen compounds faster.
Myriad Genetics Current
Chief Executive Officer
Agilent's Diagnostics and Genomics Group
President
Illumina
Vice President of Global Marketing

Key Colleagues at Startups

The people Samraat Raha works with at each company, as listed on that company's latest Form D.

Araceli Biosciences Inc. · Form D, Nov 3, 2026
Matt Beaudet
Matt Beaudet
President and CEO, director
WC
William Cortelyou
Chairman of the Board
Kirk Malloy
Kirk Malloy
Director
Sean O'Neill
Sean O'Neill
Director
Bruce Rhine
Bruce Rhine
Director

Sources

  1. SECAraceli Biosciences Inc. Form D, filed Nov 3, 2026